Table I.
Patient characteristics.
| Variable | PC group (n=24) | SR group (n=58) | P-value, T or χ2 |
|---|---|---|---|
| Mean age, years (range) | 514±10 | 58±9 | 0.08a |
| Gender | 0.68b | ||
| Male | 16 (66.67) | 33 (56.90) | |
| Female | 8 (33.33) | 25 (43.10) | |
| AFP (ng/ml) | 321±661.78 | 127±370.62 | 0.36a |
| Liver cirrhosis | 0.21b | ||
| With cirrhosis | 16 (66.67) | 39 (67.24) | |
| Without cirrhosis | 8 (33.33) | 19 (32.76) | |
| Liver function (Child-Pugh classification) | 0.30b | ||
| Class A | 19 (79.16) | 45 (77.59) | |
| Class B | 5 (20.83) | 13 (22.41) | |
| Tumor size (cm) | 2.25±0.56 | 2.35±0.49 | 0.09a |
| Serum albumin (g/dl) | 3.89±0.72 | 3.78±0.51 | 0.13a |
| Total bilirubin (mg/dl) | 0.75±0.41 | 0.87±0.54 | 0.12a |
| Platelet count (×104/mm3) | 10.92±5.74 | 13.11±3.89 | 0.02a |
| ALT (U/l) | |||
| >40 | 14 (58.33) | 42 (72.41) | 1.60b |
| ≤40 | 10 (41.67) | 16 (27.59) | |
| AST (U/l) | 0.76b | ||
| >40 | 2 (50.00) | 36 (62.07) | |
| ≤40 | 12 (50.00) | 22 (37.93) |
All data are presented as mean ± standard deviation or no. of patients (%) unless otherwise indicated.
a
T-test;
b
χ2-test. PC, percutaneous cryosurgery; SR, surgical resection; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AFT, α-fetoprotein